|
PT65486B
(en)
|
1975-08-28 |
1978-03-24 |
Lilly Co Eli |
Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
|
|
JPH0649066B2
(ja)
*
|
1985-02-14 |
1994-06-29 |
積水化学工業株式会社 |
医療用粘着シ−トもしくはテ−プ
|
|
FR2687574B1
(fr)
*
|
1992-02-25 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Nouvelle application therapeutique de derives du pyridylpyrrolothiazole carboxamide.
|
|
US5349068A
(en)
|
1992-04-15 |
1994-09-20 |
Sterling Winthrop Inc. |
1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
|
|
JPH07188017A
(ja)
*
|
1993-09-30 |
1995-07-25 |
Souyaku Gijutsu Kenkyusho:Kk |
チアジアゾール誘導体を含有する抗ウイルス剤
|
|
US5453433A
(en)
|
1994-05-13 |
1995-09-26 |
Sterling Winthrop Inc. |
Thiadiazoles and antipicornaviral compositions
|
|
US5552422A
(en)
|
1995-01-11 |
1996-09-03 |
Merck Frosst Canada, Inc. |
Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
|
|
JPH11106340A
(ja)
|
1997-10-02 |
1999-04-20 |
Sumitomo Pharmaceut Co Ltd |
Ｓｔａｔ６活性化阻害剤
|
|
US6258831B1
(en)
*
|
1999-03-31 |
2001-07-10 |
The Procter & Gamble Company |
Viral treatment
|
|
TW200519106A
(en)
|
2003-05-02 |
2005-06-16 |
Novartis Ag |
Organic compounds
|
|
GB0321003D0
(en)
*
|
2003-09-09 |
2003-10-08 |
Angeletti P Ist Richerche Bio |
Compounds, compositions and uses
|
|
US7229480B2
(en)
|
2004-02-13 |
2007-06-12 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
SE0402735D0
(sv)
|
2004-11-09 |
2004-11-09 |
Astrazeneca Ab |
Novel compounds
|
|
EP2016075A1
(en)
|
2006-05-03 |
2009-01-21 |
AstraZeneca AB |
Thiazole derivatives and their use as anti-tumour agents
|
|
GB0716292D0
(en)
|
2007-08-21 |
2007-09-26 |
Biofocus Dpi Ltd |
Imidazopyrazine compounds
|
|
HRP20151128T1
(hr)
*
|
2007-09-27 |
2015-11-20 |
Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii |
Imidazolotiadiazoli za uporabu kao inhibitori protein kinaze
|
|
EP2307425B1
(en)
*
|
2008-07-29 |
2014-03-26 |
Merck Patent GmbH |
Imidazothiadiazoles derivatives
|
|
CA2735875A1
(en)
*
|
2008-09-03 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Use of quinazoline derivatives for the treatment of viral diseases
|
|
ES2665277T3
(es)
|
2009-03-13 |
2018-04-25 |
Katholieke Universiteit Leuven K.U. Leuven R&D |
Análogos de purina y su uso como agentes inmunosupresores
|
|
US8815918B2
(en)
|
2009-04-02 |
2014-08-26 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives
|
|
GB201012889D0
(en)
|
2010-08-02 |
2010-09-15 |
Univ Leuven Kath |
Antiviral activity of novel bicyclic heterocycles
|
|
GB201015411D0
(en)
|
2010-09-15 |
2010-10-27 |
Univ Leuven Kath |
Anti-cancer activity of novel bicyclic heterocycles
|
|
WO2012088438A1
(en)
|
2010-12-22 |
2012-06-28 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
|
GB201115665D0
(en)
|
2011-09-09 |
2011-10-26 |
Univ Leuven Kath |
Autoimmune and inflammatory disorder therapy
|
|
US9309236B2
(en)
|
2011-10-05 |
2016-04-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
PI-kinase inhibitors with broad spectrum anti-infective activity
|
|
EP3409666A3
(en)
|
2012-06-07 |
2019-01-02 |
Georgia State University Research Foundation, Inc. |
Seca inhibitors and methods of making and using thereof
|
|
WO2014078813A1
(en)
|
2012-11-19 |
2014-05-22 |
Irm Llc |
Compounds and compositions for the treatment of parasitic diseases
|
|
SG11201504291SA
(en)
|
2012-12-20 |
2015-07-30 |
Ucb Biopharma Sprl |
Therapeutically active pyrazolo-pyrimidine derivatives
|
|
EP3004060B1
(en)
|
2013-05-30 |
2019-11-27 |
Plexxikon Inc. |
Compounds for kinase modulation, and indications therefor
|
|
RU2689788C2
(ru)
|
2014-01-22 |
2019-05-29 |
Куровир Аб |
ПИРАЗОЛО[1,5-а]ПИРИМИДИНЫ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ СОЕДИНЕНИЙ
|
|
JP6678599B2
(ja)
|
2014-06-13 |
2020-04-08 |
ユニバーシティー オブ ロチェスター |
小分子排出ポンプ阻害剤
|
|
GB201410816D0
(en)
|
2014-06-17 |
2014-07-30 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201410815D0
(en)
|
2014-06-17 |
2014-07-30 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201410817D0
(en)
|
2014-06-17 |
2014-07-30 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D |
Therapeutic agents
|
|
WO2016145045A1
(en)
|
2015-03-11 |
2016-09-15 |
Peloton Therapeutics, Inc. |
Compositions for use in treating glioblastoma
|
|
US10278942B2
(en)
|
2015-03-11 |
2019-05-07 |
Peloton Therapeutics, Inc. |
Compositions for use in treating pulmonary arterial hypertension
|
|
US10442788B2
(en)
|
2015-04-01 |
2019-10-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
|
WO2016168510A1
(en)
|
2015-04-17 |
2016-10-20 |
Peloton Therapeutics, Inc. |
Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
|
|
CN107949563B
(zh)
|
2015-06-24 |
2020-06-05 |
库洛维公司 |
治疗中有用的吡唑并[1,5-a]三嗪-4-胺衍生物
|
|
EP3118198A1
(en)
|
2015-07-13 |
2017-01-18 |
MMV Medicines for Malaria Venture |
Anti-malarial agents
|
|
WO2017044889A1
(en)
|
2015-09-10 |
2017-03-16 |
The Regents Of The University Of California |
Lrh-1 modulators
|
|
WO2017053192A1
(en)
|
2015-09-21 |
2017-03-30 |
The Board Of Regents Of The University Of Texas System |
Biomarkers of response to hif-2-alpha inhibition in cancer and methods for the use thereof
|
|
GB201517263D0
(en)
|
2015-09-30 |
2015-11-11 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201517264D0
(en)
|
2015-09-30 |
2015-11-11 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
GB201521767D0
(en)
|
2015-12-10 |
2016-01-27 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R&D |
Therapeutic agents
|
|
WO2017147526A1
(en)
|
2016-02-26 |
2017-08-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Pi-kinase inhibitors with anti-infective activity
|
|
WO2017223414A1
(en)
|
2016-06-24 |
2017-12-28 |
Incyte Corporation |
HETEROCYCLIC COMPOUNDS AS PI3K-γ INHIBITORS
|
|
US20190358196A1
(en)
|
2016-07-27 |
2019-11-28 |
Henry C. Lowe |
Pi 4-kinase inhibitor as a therapeutic for viral hepatitis, cancer, malaria. autoimmune disorders and inflammation, and a radiosensitizer and immunosuppressant
|